A CareForum rebroadcast: A national registry of alloantibodies
Presented by: Dr. Gagan Mathur and Dr. Jay Menitove
Solutions
You will receive an email with a link to the webinar
Presented by: Dr. Gagan Mathur and Dr. Jay Menitove
Recorded Thursday, February 9, 2023
Watch this on-demand session to review critical facts of red blood cell alloimmunization induction and sequelae and discuss strategies to prevent the dangers of evanesced antibodies and delayed hemolytic transfusion.
Top discussion points during this session:
Stay on and listen to live Q&A with Dr. Mathur, Dr. Menitove, and Dr. George Hauser, President and founder of the Alloantibody exchange.
Recorded Oct 23, 2018
WellSky only wants to send you the information you are interested in. Please fill out the form below to choose the emails you want to receive. We only send emails to subscribers. If you are an existing customer, you will continue to receive certain notifications.
Presenter: Gagan Mathur, MD
Medical Director for Transfusion Medicine, University of California Irvine Health
Dr. Gagan Mathur is a board-certified transfusion medicine physician and business management (MBA) graduate with career goal to excel as a physician leader. After finishing medical school in India, Dr. Mathur trained in pathology at University of Iowa. During his residency and fellowship training, he also completed an MBA from Tippie School of Management. Recently Dr. Mathur earned the title of Certified Physician Executive from American Association for Physician Leadership. Utilizing his formal training and interest in business management, informatics, data analytics, and healthcare administration, Dr. Mathur strives to provide effective and efficient patient care.
Presenter: Jay Menitove, MD
CEO of JEM Consulting
Jay Menitove, M.D., the former CEO/Medical Director of the Community Blood Center of Greater Kansas City, is a Clinical Professor of Pathology and Laboratory Medicine at the Kansas University Medical Center. He is board certified in internal medicine, hematology, and blood banking. He serves as an Associate Editor of Transfusion, chaired the HHS Advisory Committee on Blood and Tissue Safety and Availability, and is an AABB past-president. Dr. Menitove’s academic interests include transfusion safety, blood donation, and sustainability of the U.S. blood system. He is the author or co-author of more than 170 journal articles, textbook chapters, and other publications.
People who choose a life of caring — and the organizations and communities they serve — deserve a special kind of support. So we help them to care smarter. Liberating them to focus on the people they serve. Providing solutions that make work flow, integrate insights, and update effortlessly.
People who choose a life of caring — and the organizations and communities they serve — deserve a special kind of support. So we help them to care smarter. Liberating them to focus on the people they serve. Providing solutions that make work flow, integrate insights, and update effortlessly.
WellSky is a technology company that delivers software and services to transform an ever-growing range of care services worldwide. Building on a history of excellence and a reputation for quality, WellSky – formerly Mediware Information Systems and Kinnser Software – empowers providers to provide exceptional care, improve operational efficiency, reduce cost, and meet the challenges of their rapidly changing industries.
People who choose a life of caring — and the organizations and communities they serve — deserve a special kind of support. So we help them to care smarter. Liberating them to focus on the people they serve. Providing solutions that make work flow, integrate insights, and update effortlessly. So they're able to anticipate — and exponentially increase — the impact of care.
People who choose a life of caring — and the organizations and communities they serve — deserve a special kind of support. So we help them to care smarter. Liberating them to focus on the people they serve. Providing solutions that make work flow, integrate insights, and update effortlessly. So they're able to anticipate — and exponentially increase — the impact of care.